| Uterine Leiomyoma |
1 |
0.89 |
| Fibroma |
0 |
0.78 |
| Uterus |
0 |
0.47 |
| Pregnancy |
0 |
0.42 |
| Dysfunctional Uterine Bleeding |
0 |
0.35 |
| Fertility |
0 |
0.25 |
| Pain Management |
0 |
0.17 |
| Ablation |
0 |
0.15 |
| Radiofrequency Ablation (RFA) |
0 |
0.14 |
| Thromboembolism |
0 |
0.13 |
| Acute Pain |
0 |
0.1 |
| Adhesion |
0 |
0.1 |
| Pain |
0 |
0.1 |
| Pelvic Pain |
0 |
0.1 |
| Ultrasonography |
0 |
0.09 |
| Postoperative Pain |
0 |
0.08 |
| Quality of Life |
0 |
0.08 |
| Clinical Research |
0 |
0.07 |
| Surgery |
0 |
0.07 |
| Artery |
0 |
0.06 |
| Cesarean Delivery |
0 |
0.06 |
| Embolization |
0 |
0.06 |
| Gynecologic Surgery |
0 |
0.06 |
| Spontaneous Abortion |
0 |
0.06 |
| Contraception |
0 |
0.05 |
| Adenomyosis |
0 |
0.04 |
| Birth |
0 |
0.04 |
| Food and Drug Administration (FDA) |
0 |
0.04 |
| Hysteroscopy |
0 |
0.04 |
| Incision |
0 |
0.04 |
| laparotomy |
0 |
0.04 |
| Abdomen |
0 |
0.03 |
| Blood |
0 |
0.03 |
| Hemorrhage |
0 |
0.03 |
| Tissue |
0 |
0.03 |
| Complementary and Alternative Medicine |
0 |
0.02 |
| Anemia |
0 |
0.01 |
| Bladder |
0 |
0.01 |
| Face |
0 |
0.01 |
| Hysterectomy |
0 |
0.01 |
| Intrauterine Device |
0 |
0.01 |
| Laparoscopy |
0 |
0.01 |
| Magnetic Resonance Imaging |
0 |
0.01 |
| Meta-Analysis |
0 |
0.01 |
| Placenta Accreta |
0 |
0.01 |
| Placental Abruption |
0 |
0.01 |
| Postoperative |
0 |
0.01 |
| Scar |
0 |
0.01 |
| Surgical Complication |
0 |
0.01 |